IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1355 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Effects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
Mitra Niafar,Leili Pourafkari,Kavus Shahsavarinia,Nushin Milanchian,Farhad Niafar,Nader Nader
Journal of Cardiovascular and Thoracic Research.2016;8(1)8
[DOI]
2Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus
Jessica L Kerr,Erin M Timpe,Katherine A Petkewicz
Annals of Pharmacotherapy.2010;44(11)1777
[DOI]
3A Systematic Account of Pathogenesis, Diagnosis and Pharmacotherapy of Metabolic Syndrome: Things We Need to Know
R. Mahajan,K. Gupta,V. Kapoor
International Journal of Pharmacology.2010;6(4)338
[DOI]
4The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Kira V. Derkach,Vera M. Bondareva,Oxana V. Chistyakova,Lev M. Berstein,Alexander O. Shpakov
International Journal of Endocrinology.2015;2015(4)1
[DOI]
5The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Patricio Atanes,Shanta J. Persaud
International Journal of Endocrinology.2020;2015(4)367
[DOI]
6The effect of 2-month bromocriptine treatment on the activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes
K. V. Derkach,V. M. Bondareva,I. V. Moiseyuk,A. O. Shpakov
Cell and Tissue Biology.2015;9(5)395
[DOI]
7Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
Alexander O Shpakov,Kira V Derkach,Lev M Berstein
Future Science OA.2015;1(3)395
[DOI]
8Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I
Lev M Vieira,Lev M Souto,Lev M Sánchez-López,Lev M Machado,Lev M Severino,Lev M Jose,Lev M Santini,Lev M Fortuna,Lev M García,Lev M Silva,Lev M Souto
Pharmaceuticals.2019;12(4)152
[DOI]
9Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel
S. Kalra,S. Ghosh,A.K. Das,T. Nair,S. Bajaj,G. Priya,R.N. Mehrotra,S. Das,P. Shah,V. Deshmukh,M. Chawla,D. Sanyal,S. Chandrasekaran,D. Khandelwal,A. Joshi,F. Eliana,H. Permana,M.D. Fariduddin,P.K. Shrestha,D. Shrestha,S. Kahandawa,M. Sumanathilaka,A. Shaheed,A.A. Rahim,A. Orabi,A. Al-ani,W. Hussein,D. Kumar,K. Shaikh
Indian Heart Journal.2020;72(1)7
[DOI]
10Therapeutic Approaches for Zika Virus Infection of the Nervous System
Rachel P. M. Abrams,Jamie Solis,Avindra Nath
Neurotherapeutics.2017;14(4)1027
[DOI]
11Antihyperglycemic, Antihyperlipidemic and Cardioprotective Profile of Bromocriptine, Glibenclamide and Metformin Combination in Dexamethasone-induced Hyperglycemic Rats
Adejuwon Adewale Adeneye,Joseph Abayomi Olagunju
Pharmacologia.2012;3(12)665
[DOI]
12Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
Zachary J. Farino,Travis J. Morgenstern,Julie Vallaghe,Nathalie Gregor,Prashant Donthamsetti,Paul E. Harris,Nicolas Pierre,Robin Freyberg,Fabienne Charrier-Savournin,Jonathan A. Javitch,Zachary Freyberg,Faramarz Dehghani
PLOS ONE.2016;11(2)e0148684
[DOI]
13Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
Kyriaki Savva,Margarita Zachariou,Anastasis Oulas,George Minadakis,Kleitos Sokratous,Nikolas Dietis,George M. Spyrou
PLOS ONE.2019;11(2)85
[DOI]
14Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study
Elisabetta Esposito,Paolo Mariani,Laura Ravani,Catia Contado,Mattia Volta,Simone Bido,Markus Drechsler,Serena Mazzoni,Enea Menegatti,Michele Morari,Rita Cortesi
European Journal of Pharmaceutics and Biopharmaceutics.2012;80(2)306
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow